Evaluating parental personal utility of pediatric genetic and genomic testing in a diverse, multilingual population
Priya N. Marathe,
Sabrina A. Suckiel,
Katherine E. Bonini,
Nicole R. Kelly,
Laura Scarimbolo,
Beverly J. Insel,
Jacqueline A. Odgis,
Monisha Sebastin,
Michelle A. Ramos,
Miranda Di Biase,
Katie M. Gallagher,
Kaitlyn Brown,
Jessica E. Rodriguez,
Nicole Yelton,
Karla Lopez Aguiñiga,
Michelle A. Rodriguez,
Estefany Maria,
Jessenia Lopez,
Randi E. Zinberg,
George A. Diaz,
John M. Greally,
Noura S. Abul-Husn,
Laurie J. Bauman,
Bruce D. Gelb,
Melissa P. Wasserstein,
Eimear E. Kenny,
Carol R. Horowitz
Affiliations
Priya N. Marathe
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Sabrina A. Suckiel
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Katherine E. Bonini
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Nicole R. Kelly
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Laura Scarimbolo
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Beverly J. Insel
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Jacqueline A. Odgis
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Monisha Sebastin
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Michelle A. Ramos
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Miranda Di Biase
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Katie M. Gallagher
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Kaitlyn Brown
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Jessica E. Rodriguez
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Nicole Yelton
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Karla Lopez Aguiñiga
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Michelle A. Rodriguez
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Estefany Maria
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Jessenia Lopez
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Randi E. Zinberg
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
George A. Diaz
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
John M. Greally
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Noura S. Abul-Husn
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Laurie J. Bauman
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Bruce D. Gelb
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Melissa P. Wasserstein
Department of Pediatrics, Division of Pediatric Genetic Medicine, Children’s Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA
Eimear E. Kenny
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Corresponding author
Carol R. Horowitz
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Corresponding author
Summary: There is increasing evidence of the clinical utility of genetic and genomic testing (GT); however, factors influencing personal utility of GT, especially in diverse, multilingual populations, remain unclear. We explored these factors in a diverse cohort of parents/guardians (participants) whose children received clinical GT through the NYCKidSeq program. A total of 847 participants completed surveys at baseline, post-results disclosure, and 6 months (6m) post-results. The largest population groups were Hispanic/Latino(a) (48%), White/European American (24%), and Black/African American (16%). Personal utility was assessed using the Personal Utility (PrU) scale, adapted for pediatric populations and included on the surveys. Three PrU subscales were identified using factor analysis: practical, educational, and parental psychological utility. Overall personal utility summary score and the three subscales significantly decreased after receiving results and over time. Hispanic/Latino(a) participants identified greater overall personal utility than European American and African American participants at all time points (p < 0.001) as did participants whose children received positive/likely positive results compared with those with negative and uncertain results (post-results: p < 0.001 and p < 0.001; 6m post-results: p = 0.002 and p < 0.001, respectively). Post-results, higher subscale scores were associated with lower education levels (practical, parental psychological: p ≤ 0.02) and higher levels of trust in the healthcare system (practical, parental psychological: p ≤ 0.04). These findings help to understand the perspectives of diverse parents/guardians, which is critical to tailoring pre- and post-test counseling across a variety of populations and clinical settings.